Clinical Study Protocol Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011 in Infants Aged Between 6-12 months Old.

Trial Profile

Clinical Study Protocol Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011 in Infants Aged Between 6-12 months Old.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jul 2012

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Pharmacodynamics
  • Sponsors Adimmune Corporation
  • Most Recent Events

    • 19 Jan 2012 Actual start date (1 Nov 2010) added as reported by ClinicalTrials.gov.
    • 19 Jan 2012 Actual end date (1 Sep 2011) added as reported by ClinicalTrials.gov.
    • 19 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top